See below: Benitec Biopharma CEO and Executive Chairman Jerel A. Banks, M.D. and Ph.D said. “Our team has an unprecedented opportunity to develop a novel genetic medicine that could facilitate clinically meaningful patient benefit in a potentially fatal disorder for which profound unmet medical need exists,"